Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Hemolysis and Reactive Oxygen Species in Red Blood Cells of Non-Transfusion Dependent Hemolytic Anemic Patients Due to β-Thalassemia/Hb E Disease

Thidarat Suksangpleng, Kalaya Tachavanich, Vip Viprakasit

Blood (2024) 144 (Supplement 1): 2479.

https://doi.org/10.1182/blood-2024-201324

Published: 2024

Journal Articles

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hemolytic Anemia Patient Due to Krϋppel-like Factor 1 Mutations

Thidarat Suksangpleng, Kalaya Tachavanich, Vip Viprakasit

Blood (2023) 142 (Supplement 1): 1071.

https://doi.org/10.1182/blood-2023-179130

Published: 2023

Journal Articles

Phenotypic Corrections of Ex Vivo Erythrocytes Derived from Chronic Hemolytic Anemia Patients Due to Krϋppel-like Factor 1 ( KLF-1 ) Mutations By AG-348: A Novel Synthetic Pyruvate Kinase Activator

Thidarat Suksangpleng, PhD, Kalaya Tachavanich, M.Sc., Suchada Riolueang, MSc, Supachai Ekwattanakit, PhDMD, Vip Viprakasit, MD DPhil

Blood (2019) 134 (Supplement_1): 2220.

https://doi.org/10.1182/blood-2019-131720

Published: 2019

Journal Articles

Identification of a Digenic Inheritance of Pklr and KLF1 Mutations Resulting in Hemolytic Anemia in a Neonate from a Study of Genotype-Phenotype Correlation of Globin, Pklr and KLF1 in Thai Patients with Pyruvate Kinase (PK) Deficiency

Supachai Ekwattanakit, BSc, PhD MD, Suchada Riolueang, M.Sc., Kalaya Tachavanich, Hitoshi Kanno, MDPhD, Vip Viprakasit, MD DPhil, Thidarat Suksangpleng, PhD, Vorravarn S Tanphaichitr

Blood (2017) 130 (Supplement 1): 3477.

https://doi.org/10.1182/blood.V130.Suppl_1.3477.3477

Published: 2017

Journal Articles

Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression

Vip Viprakasit, Supachai Ekwattanakit, Suchada Riolueang, Nipon Chalaow, Chris Fisher, Karen Lower, Hitoshi Kanno, Kalaya Tachavanich, Sasithorn Bejrachandra, Jariya Saipin, Monthana Juntharaniyom, Kleebsabai Sanpakit, Voravarn S. Tanphaichitr, Duantida Songdej, Christian Babbs, Richard J. Gibbons, Sjaak Philipsen, Douglas R. Higgs

Blood (2014) 123 (10): 1586–1595.

https://doi.org/10.1182/blood-2013-09-526087

Published: 2014

Includes: Supplemental data

Journal Articles

Identification of a Novel IL7RA Mutation (444_450insA) Caused Marked Reduction in CD127 Expression from a Cohort Molecular Analysis of Severe Combined Immunodeficiency (T − , B + , NK + SCID) in Thailand.

Vip Viprakasit, MD, PhD, Yuwarat Monteerarat, BSc, Orathai Piboonpocanun, MD, Kleebsabai Sanpakit, MD, Worrawut Chinchang, MSc, Kalaya Tachavanich, MSc, Nualanong Visitsunthorn, MD, Visith Thongboonkerd, MD, Prakit Vichyanond, MD

Blood (2006) 108 (11): 1247.

https://doi.org/10.1182/blood.V108.11.1247.1247

Published: 2006

Journal Articles

Impairment of Plasmodium falciparum Growth in Thalassemic Red Blood Cells: Further Evidence by Using Biotin Labeling and Flow Cytometry

Kovit Pattanapanyasat, Kosol Yongvanitchit, Pongsri Tongtawe, Kalaya Tachavanich, Wanchai Wanachiwanawin, Suthat Fucharoen, Douglas S. Walsh

Blood (1999) 93 (9): 3116–3119.

https://doi.org/10.1182/blood.V93.9.3116

Published: 1999

NARROW

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Hemolysis and Reactive Oxygen Species in Red Blood Cells of Non-Transfusion Dependent Hemolytic Anemic Patients Due to β-Thalassemia/Hb E Disease

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hemolytic Anemia Patient Due to Krϋppel-like Factor 1 Mutations

Phenotypic Corrections of Ex Vivo Erythrocytes Derived from Chronic Hemolytic Anemia Patients Due to Krϋppel-like Factor 1 ( KLF-1 ) Mutations By AG-348: A Novel Synthetic Pyruvate Kinase Activator

Identification of a Digenic Inheritance of Pklr and KLF1 Mutations Resulting in Hemolytic Anemia in a Neonate from a Study of Genotype-Phenotype Correlation of Globin, Pklr and KLF1 in Thai Patients with Pyruvate Kinase (PK) Deficiency

Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression

Identification of a Novel IL7RA Mutation (444_450insA) Caused Marked Reduction in CD127 Expression from a Cohort Molecular Analysis of Severe Combined Immunodeficiency (T − , B + , NK + SCID) in Thailand.

Impairment of Plasmodium falciparum Growth in Thalassemic Red Blood Cells: Further Evidence by Using Biotin Labeling and Flow Cytometry

Email alerts

ASH Publications

American Society of Hematology

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Hemolysis and Reactive Oxygen Species in Red Blood Cells of Non-Transfusion Dependent Hemolytic Anemic Patients Due to β-Thalassemia/Hb E Disease

Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hemolytic Anemia Patient Due to Krϋppel-like Factor 1 Mutations

Phenotypic Corrections of Ex Vivo Erythrocytes Derived from Chronic Hemolytic Anemia Patients Due to Krϋppel-like Factor 1 ( KLF-1 ) Mutations By AG-348: A Novel Synthetic Pyruvate Kinase Activator

Identification of a Digenic Inheritance of Pklr and KLF1 Mutations Resulting in Hemolytic Anemia in a Neonate from a Study of Genotype-Phenotype Correlation of Globin, Pklr and KLF1 in Thai Patients with Pyruvate Kinase (PK) Deficiency

Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression

Identification of a Novel IL7RA Mutation (444_450insA) Caused Marked Reduction in CD127 Expression from a Cohort Molecular Analysis of Severe Combined Immunodeficiency (T − , B + , NK + SCID) in Thailand.

Impairment of Plasmodium falciparum Growth in Thalassemic Red Blood Cells: Further Evidence by Using Biotin Labeling and Flow Cytometry

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only